For instance, increased expression of miR-95 in human breast cancer specimens indicates the resistance to radiation treatment by targeting sphingosine-1-phosphate phosphatase 1 (SGPP1), an antagonist of sphingosine-1-phosphate signaling in TNBC cells [198]. Here, SGPP1 is linked to breast cancer.